Carisma Therapeutics Dividends
| CARM Stock | 0.56 0.13 18.84% |
As of the 12th of December 2024, Dividends Paid is likely to drop to about 117.6 K. In addition to that, Dividend Paid And Capex Coverage Ratio is likely to drop to -75.3. Carisma Therapeutics' past performance could be the main factor of why investors trade Carisma Therapeutics stock today. Investors should clearly understand every aspect of the Carisma Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Carisma Therapeutics' dividend schedule and payout information. Carisma Therapeutics dividends can also provide a clue to the current valuation of Carisma Therapeutics.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 132.3 K | 117.6 K | |
| Dividend Paid And Capex Coverage Ratio | (71.71) | (75.30) |
Carisma |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Carisma Therapeutics must own a stock before its ex-dividend date to receive its next dividend.
Carisma Therapeutics Dividends Paid Over Time
Today, most investors in Carisma Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Carisma Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Carisma Therapeutics dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Carisma Therapeutics Expected Dividend Income Per Share
Dividend payment represents part of Carisma Therapeutics' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Carisma Therapeutics. Carisma Therapeutics' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$0.3 Bottom Scenario | 0.63 | $1.2 Top Scenario |
One Year
Carisma Therapeutics expected dividend income per share adjusted for ongoing price standard deviation
Carisma Therapeutics Past Distributions to stockholders
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Carisma Therapeutics. If investors know Carisma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Carisma Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share 0.493 | Quarterly Revenue Growth (0.12) | Return On Assets (0.56) | Return On Equity (3.63) |
The market value of Carisma Therapeutics is measured differently than its book value, which is the value of Carisma that is recorded on the company's balance sheet. Investors also form their own opinion of Carisma Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Carisma Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Carisma Therapeutics' market value can be influenced by many factors that don't directly affect Carisma Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Carisma Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Carisma Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Carisma Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.